These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 28797868)
1. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study. Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868 [TBL] [Abstract][Full Text] [Related]
2. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling. Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099 [TBL] [Abstract][Full Text] [Related]
3. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors. Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy. Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study. Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4-6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo. Myftiu B; Hundozi Z; Sermaxhaj F; Blyta A; Shala N; Jashari F; Qorraj Bytyqi H; Hyseni E; Kurtishi I Med Sci Monit; 2022 Aug; 28():e937856. PubMed ID: 36042691 [TBL] [Abstract][Full Text] [Related]
7. The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums. Lavoie Smith EM; Cohen JA; Pett MA; Beck SL Oncol Nurs Forum; 2011 Mar; 38(2):133-42. PubMed ID: 21356652 [TBL] [Abstract][Full Text] [Related]
8. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial. Kurt S; Can G Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627 [TBL] [Abstract][Full Text] [Related]
9. Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLARE technique: a novel technique to detect neural small fiber dysfunction. Sharma S; Venkitaraman R; Vas PR; Rayman G Brain Behav; 2015 Jul; 5(7):e00354. PubMed ID: 26221574 [TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics. Bennedsgaard K; Ventzel L; Andersen NT; Themistocleous AC; Bennett DL; Jensen TS; Tankisi H; Finnerup NB J Peripher Nerv Syst; 2020 Dec; 25(4):377-387. PubMed ID: 32902058 [TBL] [Abstract][Full Text] [Related]
11. A Randomized Controlled Trial to Assess the Effectiveness of Muscle Strengthening and Balancing Exercises on Chemotherapy-Induced Peripheral Neuropathic Pain and Quality of Life Among Cancer Patients. Dhawan S; Andrews R; Kumar L; Wadhwa S; Shukla G Cancer Nurs; 2020; 43(4):269-280. PubMed ID: 30888982 [TBL] [Abstract][Full Text] [Related]
12. Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain. Bechakra M; Nieuwenhoff MD; van Rosmalen J; Groeneveld GJ; Scheltens-de Boer M; Sonneveld P; van Doorn PA; de Zeeuw CI; Jongen JL Mol Pain; 2018; 14():1744806918797042. PubMed ID: 30152246 [TBL] [Abstract][Full Text] [Related]
13. A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis. Fontes F; Pereira S; Castro-Lopes JM; Lunet N Breast; 2016 Oct; 29():31-8. PubMed ID: 27394676 [TBL] [Abstract][Full Text] [Related]
14. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164 [TBL] [Abstract][Full Text] [Related]
15. An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Andersen Hammond E; Pitz M; Steinfeld K; Lambert P; Shay B Neurorehabil Neural Repair; 2020 Mar; 34(3):235-246. PubMed ID: 31976819 [No Abstract] [Full Text] [Related]
16. Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain. Blanton HL; Brelsfoard J; DeTurk N; Pruitt K; Narasimhan M; Morgan DJ; Guindon J Drugs; 2019 Jun; 79(9):969-995. PubMed ID: 31127530 [TBL] [Abstract][Full Text] [Related]
17. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment. Andersen Hammond E; Pitz M; Shay B Neurorehabil Neural Repair; 2019 Oct; 33(10):792-799. PubMed ID: 31342880 [TBL] [Abstract][Full Text] [Related]
18. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain. Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187 [TBL] [Abstract][Full Text] [Related]
19. Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies. Youk J; Kim YS; Lim JA; Shin DY; Koh Y; Lee ST; Kim I PLoS One; 2017; 12(8):e0183491. PubMed ID: 28827818 [TBL] [Abstract][Full Text] [Related]
20. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies. Krøigård T; Schrøder HD; Qvortrup C; Eckhoff L; Pfeiffer P; Gaist D; Sindrup SH Eur J Neurol; 2014 Apr; 21(4):623-9. PubMed ID: 24460946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]